Erratum: Immunological commonalities and distinctions between airway and digestive immunity [Trends Immunol. 29 (2008), 505-513] (DOI:10.1016/j.it.2008.07.008);Immunological commonalities and distinctions between airway and digestive immunity

Trends in Immunology

Volumn 29, Issue 11, 2008, Pages 505-513

  Kunisawa, Jun ^a,b   Nochi, Tomonori ^a   Kiyono, Hiroshi ^a,b,c  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; IMMUNOGLOBULIN A; INFLUENZA VACCINE; MUCORICE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

AIRWAY; BACTERIAL INFECTION; CELL MIGRATION; DIGESTIVE SYSTEM; EPITHELIUM; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGY; INTESTINE; LYMPHOCYTE; LYMPHOID TISSUE; MUCOSA; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; PEYER PATCH; PHENOTYPE; REGULATORY MECHANISM; REVIEW; VIBRIO CHOLERAE;

EID: 53849114631     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.01.001     Document Type: Erratum

References (107)

1. Kiyono H., et al. The mucosal immune system. In: Paul W.E. (Ed). Fundamental Immunology (2008), Lippincott-Raven 983-1030
2. Kiyono H., and Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4 (2004) 699-710
3. Kunisawa J., et al. Mucosa-associated lymphoid tissues in aerodigestive tract: their shared and divergent traits and their importance to the orchestration of mucosal immune system. Curr. Mol. Med. 5 (2005) 557-572
4. Debertin A.S., et al. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin. Exp. Immunol. 134 (2003) 503-507
5. Owen R.L., and Jones A.L. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 66 (1974) 189-203
6. Karchev T., and Kabakchiev P. M-cells in the epithelium of the nasopharyngeal tonsil. Rhinology 22 (1984) 201-210
7. Kraehenbuhl J.P., and Neutra M.R. Epithelial M cells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16 (2000) 301-332
8. +, and double-negative Peyer's patch dendritic cells. J. Immunol. 166 (2001) 4884-4890
9. Iwasaki A., and Kelsall B.L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191 (2000) 1381-1394
10. Salazar-Gonzalez R.M., et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24 (2006) 623-632
11. Fleeton M.N., et al. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200 (2004) 235-245
12. Macpherson A.J., and Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303 (2004) 1662-1665
13. Contractor N., et al. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFβ, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 179 (2007) 2690-2694
14. Porgador A., et al. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect. Immun. 66 (1998) 5876-5881
15. Rangel-Moreno J., et al. Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue. J. Immunol. 175 (2005) 4904-4913
16. Dieu M.C., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
17. Bjorck P., et al. Human interdigitating dendritic cells directly stimulate CD40-activated naive B cells. Eur. J. Immunol. 27 (1997) 1266-1274
18. Summers K.L., et al. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am. J. Pathol. 159 (2001) 285-295
19. Hiroi T., et al. Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur. J. Immunol. 28 (1998) 3346-3353
20. Takamura K., et al. Regulatory role of lymphoid chemokine CCL19 and CCL21 in the control of allergic rhinitis. J. Immunol. 179 (2007) 5897-5906
21. Takayama N., et al. Regulatory role of Peyer's patches for the inhibition of OVA-induced allergic diarrhea. Clin. Immunol. 123 (2007) 199-208
22. Cerutti A., and Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 28 (2008) 740-750
23. Tezuka H., et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448 (2007) 929-933
24. Gohda M., et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer's patches for intestinal IgA responses. J. Immunol. 180 (2008) 5335-5343
25. Butcher E.C., et al. Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J. Immunol. 129 (1982) 2698-2707
26. Shimoda M., et al. Isotype-specific selection of high affinity memory B cells in nasal-associated lymphoid tissue. J. Exp. Med. 194 (2001) 1597-1607
27. Brandtzaeg P., et al. Immunoglobulin-producing cells in clinically normal, hyperplastic and inflamed human palatine tonsils. Acta Otolaryngol. Suppl. 360 (1979) 211-215
28. Iwasato T., et al. Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor β and lipopolysaccharide. J. Exp. Med. 175 (1992) 1539-1546
29. Yamanaka T., et al. M cell pockets of human Peyer's patches are specialized extensions of germinal centers. Eur. J. Immunol. 31 (2001) 107-117
30. Liu Y.J., et al. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2 (1995) 239-248
31. Adachi S., et al. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9 (1997) 507-514
32. Adachi S., et al. Essential role of IL-7 receptor α in the formation of Peyer's patch anlage. Int. Immunol. 10 (1998) 1-6
33. - cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11 (1999) 643-655
34. Veiga-Fernandes H., et al. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 446 (2007) 547-551
35. Yokota Y., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397 (1999) 702-706
36. Sun Z., et al. Requirement for RORγ in thymocyte survival and lymphoid organ development. Science 288 (2000) 2369-2373
37. Kurebayashi S., et al. Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10132-10137
38. + cells. Immunity 17 (2002) 31-40
39. Fukuyama S., et al. Cutting edge: Uniqueness of lymphoid chemokine requirement for the initiation and maturation of nasopharynx-associated lymphoid tissue organogenesis. J. Immunol. 177 (2006) 4276-4280
40. Harmsen A., et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-α (LTα) and retinoic acid receptor-related orphan receptor-γ, but the organization of NALT is LTα dependent. J. Immunol. 168 (2002) 986-990
41. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441 (2006) 235-238
42. Mangan P.R., et al. Transforming growth factor-β induces development of the Th17 lineage. Nature 441 (2006) 231-234
43. McGeachy M.J., et al. TGF- β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain Th17 cell-mediated pathology. Nat. Immunol. 8 (2007) 1390-1397
44. Awasthi A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8 (2007) 1380-1389
45. Stumhofer J.S., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8 (2007) 1363-1371
46. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
47. Sun C.M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 Treg cells via retinoic acid. J. Exp. Med. 204 (2007) 1775-1785
48. Benson M.J., et al. All-trans retinoic acid mediates enhanced Treg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 (2007) 1765-1774
49. Mucida D., et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007) 256-260
50. Stumbles P.A., et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J. Exp. Med. 188 (1998) 2019-2031
51. de Heer H.J., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200 (2004) 89-98
52. + regulatory T cells. J. Exp. Med. 203 (2006) 2649-2660
53. Idzko M., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13 (2007) 913-919
54. Kamada N., et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol. 175 (2005) 6900-6908
55. Hirotani T., et al. The nuclear IκB protein IκBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J. Immunol. 174 (2005) 3650-3657
56. Takabayshi K., et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 24 (2006) 475-487
57. Mestecky J., et al. Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science 171 (1971) 1163-1165
58. Mostov K.E., and Deitcher D.L. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 46 (1986) 613-621
59. Kunisawa J., and Kiyono H. A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. Cell. Mol. Life Sci. 62 (2005) 1308-1321
60. Kroese F.G., et al. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int. Immunol. 1 (1989) 75-84
61. Macpherson A.J., et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288 (2000) 2222-2226
62. Litinskiy M.B., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3 (2002) 822-829
63. von Bulow G.U., et al. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
64. Mestecky J., et al. Mucosal Immunoglobulins. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology. 3rd edn (2005), Academic Press, San Diego 153-182
65. He B., et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26 (2007) 812-826
66. Kunisawa J., et al. Intraepithelial lymphocytes: their shared and divergent immunological behaviors in the small and large intestine. Immunol. Rev. 215 (2007) 136-153
67. Jang M.H., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6110-6115
68. Rescigno M., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2 (2001) 361-367
69. Niess J.H., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
70. Chieppa M., et al. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203 (2006) 2841-2852
71. Martinoli C., et al. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 27 (2007) 975-984
72. Teitelbaum R., et al. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10 (1999) 641-650
73. Jahnsen F.L., et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol. 177 (2006) 5861-5867
74. Schwab S.R., and Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 8 (2007) 1295-1301
75. Kunisawa J., et al. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. Blood 109 (2007) 3749-3756
76. Kunisawa J., et al. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 204 (2007) 2335-2348
77. Kunisawa J., et al. Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFκB-inducing kinase in stromal cells. Blood 111 (2008) 4646-4652
78. Brinkmann V., and Baumruker T. Pulmonary and vascular pharmacology of sphingosine 1-phosphate. Curr. Opin. Pharmacol. 6 (2006) 244-250
79. + T-regulatory cells and enhances their functional activity. J. Immunol. 175 (2005) 7973-7980
80. Kurashima Y., et al. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J. Immunol. 179 (2007) 1577-1585
81. - effector memory T cell-mediated colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G267-G274
82. Idzko M., et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 116 (2006) 2935-2944
83. Berlin C., et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74 (1993) 185-195
84. Kunkel E.J., et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192 (2000) 761-768
85. Iwata M., et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
86. Mora J.R., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314 (2006) 1157-1160
87. + lymphocytes in ileal Peyer's patches of vitamin A deficient rats. Clin. Exp. Immunol. 130 (2002) 404-408
88. Campbell J.J., et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J. Immunol. 166 (2001) 2842-2848
89. Ray S.J., et al. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20 (2004) 167-179
90. + T cells into the interstitium of the normal lung. J. Clin. Invest. 115 (2005) 3473-3483
91. Kunisawa J., et al. Mucosal S-IgA enhancement: development of safe and effective mucosal adjuvants and mucosal antigen delivery vehicles. In: Kaetzel C.S. (Ed). Mucosal Immune Defense: Immunoglobulin A (2007), Kluwer Academic/Plenum Publishers, New York 345-389
92. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 4, Suppl (2005) S45-S53
93. Chumakov K., et al. Vaccination against polio should not be stopped. Nat. Rev. Microbiol. 5 (2007) 952-958
94. De Vos B., et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23 10, Suppl (2004) S179-S182
95. Belshe R., et al. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev. Vaccines 3 (2004) 643-654
96. Belshe R.B., et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356 (2007) 685-696
97. Ambrose C.S., et al. Live attenuated influenza vaccine in children. Semin. Pediatr. Infect. Dis. 17 (2006) 206-212
98. Hill D.R., et al. Oral cholera vaccines: use in clinical practice. Lancet Infect. Dis. 6 (2006) 361-373
99. Itoh Y., et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26 (2008) 562-572
100. Ichinohe T., et al. Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microbes Infect. 9 (2007) 1333-1340
101. Nochi T., et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10986-10991
102. Manocha M., et al. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Vaccine 23 (2005) 5599-5617
103. Wang X., et al. Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine 23 (2005) 3836-3842
104. Higgins L.M., et al. In vivo phage display to identify M cell-targeting ligands. Pharm. Res. 21 (2004) 695-705
105. Clark M.A., et al. M-cell surface β1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66 (1998) 1237-1243
106. Kandori H., et al. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp. Anim. 45 (1996) 155-160
107. Nochi T., et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 204 (2007) 2789-2796